Group One Trading
PRAX icon

Group One Trading’s Praxis Precision Medicines PRAX Stock Holding History

Group One Trading’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.6K Sell
129
-5,410
-98% -$1.67M ﹤0.01% 5395
2025
Q4 		$1.63M Sell
5,539
-11,089
-67% -$2.07M ﹤0.01% 2454
2025
Q3 		$881K Buy
+16,628
New +$806K ﹤0.01% 3164
2025
Q2 		– Sell
-10,927
Closed -$416K – 8505
2025
Q1 		$414K Buy
+10,927
New +$682K ﹤0.01% 3285
2024
Q4 		– Sell
-60,818
Closed -$4.4M – 7815
2024
Q3 		$3.5M Buy
+60,818
New +$3.29M 0.01% 1283
2024
Q2 		– Sell
-13,522
Closed -$639K – 7326
2024
Q1 		$825K Buy
13,522
+13,362
+8,351% +$599K ﹤0.01% 2257
2023
Q4 		$3.56K Sell
160
-17
-10% -$306 ﹤0.01% 6640
2023
Q3 		$4.53K Buy
177
+165
+1,375% +$3.12K ﹤0.01% 6742
2023
Q2 		$206 Sell
12
-2,501
-100% -$38.3K ﹤0.01% 7467
2023
Q1 		$30.5K Buy
+2,513
New +$106K ﹤0.01% 5227
2022
Q4 		– Sell
-248
Closed -$8K – 7909
2022
Q3 		$8K Sell
248
-26
-9% -$1.29K ﹤0.01% 6640
2022
Q2 		$10K Buy
274
+253
+1,205% +$27K ﹤0.01% 6768
2022
Q1 		$3K Buy
+21
New +$4.31K ﹤0.01% 7643

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Group One Trading's PRAX Position: Q1 2026 in Review

Group One Trading reduced its Praxis Precision Medicines (PRAX) stake by 98% in Q1 2026, selling an estimated $1.67M and leaving 129 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5395.

Group One Trading first reported a position in PRAX in Q1 2022 and has held it in 13 quarters since. The position peaked at $3.5M in Q3 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Group One Trading held 129 shares of Praxis Precision Medicines worth $41.6K as of Q1 2026.
  • Group One Trading sold 5,410 Praxis Precision Medicines shares in Q1 2026, an estimated $1.67M.
  • Praxis Precision Medicines made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5395 holding.
  • Group One Trading first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 13 quarters since.
  • Group One Trading's Praxis Precision Medicines position peaked at $3.5M in Q3 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.